Review Article
Biotechnological applications of supersonic cluster beam-depositednanostructured thin films: Bottom-up engineering to optimizecell–protein–surface interactions
Ajay Vikram Singh1,2
1Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, New York 12180-35902Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180
Received 1 November 2012; revised 3 January 2013; accepted 4 January 2013
Published online 21 March 2013 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/jbm.a.34601
Abstract: Technological innovations in biomaterial sciences
harness nanoparticle (NP) production, manipulation, and dep-
osition with supreme precision, enabling the development of
industrial processes. This review first discusses the basic
components of this approach, introducing cluster sources,
experimental apparatus, and growth mechanisms for NP
formation. The second part of this review provides an
overview of how the nanoscale bottom-up engineering can
control protein adsorption, which in turn determines the fate
of nanostructured coating for prokaryotic and mammalian
(primary and stem) cell interactions. In addition, we briefly
address the implications of the cluster beam deposition tech-
nique for nanostructuration of biocompatible microdevices
and its potential as a facile coating method to promote
protein–surface interactions for microarray applications in
biotechnology. VC 2013 Wiley Periodicals, Inc. J Biomed Mater Res
Part A: 101A: 2994–3008, 2013.
Key Words: nanocluster, AFM, microarray, cell–surface inter-
actions, high throughput
How to cite this article: Singh AV. 2013. Biotechnological applications of supersonic cluster beam-deposited nanostructured thinfilms: Bottom-up engineering to optimize cell–protein–surface interactions. J Biomed Mater Res Part A 2013:101A:2994–3008.
INTRODUCTION
Nanoparticle (NP) applications have a long-stranding his-tory, with aerosol productions and robust steel coatingsdating back 2300 and 1800 years, respectively.1,2 In theindustrial realm, NPs have been used well before the adventof nanotechnology as both fillers (carbon in rubber tires)3
and additives (TiO2 in dye and paints).4,5 In the last fewyears, technological innovations and advances have ledresearchers to understand the complex interplay ofnanobiointeractions which stimulated the development ofmedicinal devices and drug-delivery systems based on NPs.6
However, further progress depends on fabricating new pro-tocols for superior NPs productions with controlled size/shape and biocompatible surface functionalities. In the longterm, nanoscience and technology (NST) either complementand strengthen existing technologies or substitute obsoletetechniques.7
Like other paradigms of science and technology, thecommercial success of NST depends on funding opportuni-ties and minimization of cost involved in scaling up at anindustrial level. The prerequisite of core manufacturing
areas containing NPs and nanomaterials in device platformneed capability of integrating different components in adefinite hierarchy defining structure and chemical composi-tions.7 This fact is closely associated with collaborativecommons of economic production technologies such assemiconductor industry, which improve in performance perunit cost.8 This could be achieved by synthesis of controlleddimensions with desired structure and chemical status ofNPs and meticulously position transfer on suitable matrices(bottom-up engineering).9 The care must be taken to main-tain a structure–function relationship of NPs in definedmatrices or areas. Lately, a technological breakthrough isachieved by manipulating and replicating micronanoscaleparticle in nonwetting templates (PRINT) to fabricate shape-and size-specific microparticles and NPs.10,11 Manipulationand controlled replications of PRINT technology put forwardthe ability to sort the objects in terms of a size or geometry,and positions. This in turn restores precise control overshape, size, surface stiffness, and modulus. Including PRINT,most of the controlled fabrication technologies are limitedto polymeric and/or biomolecular (protein/peptide)-specific
Correspondence to: A. V. Singh; e-mail: [email protected]
Contract grant sponsors: Department of Biomedical Engineering (BME), Rensselaer Polytechnic Institute (RPI; AVS)
2994 VC 2013 WILEY PERIODICALS, INC.
NPs fabrication. However, inorganic metal and metal oxidesas biocompatible surface coating for implants and prostheticdevices in vivo, and lab-on-a-chip platforms for cell microar-ray/reverse transfection assays, yet to witness technologicalsuccess.12–14
Conventional route for nanostructuredmaterial productionNanostructured materials covers a vast area of materials atnanoscale as thin film metal and metal oxide coating forenergy applications and enhance mechanical stability ofsurfaces. Biocompatible transition metal oxides (e.g., gold,silver, titania, and zirconia, iron is excluded as it is toxic tocells15 are among the most popular nanostructured materi-als for creating biocompatible surfaces and functional bioen-gineered materials for promoting tissue, organs and cellularmatrix interaction.16 A fascinating prospect of engineeringbiopolymer via docking nanoscale peptides, proteins, carbo-hydrates, and lipid moieties makes them particularly suita-ble for tissue engineering and scaffold design. Anotheremerging area in nanomedicine which involves in vivoinvasive and noninvasive theranostic (therapy þ diagnosis)application17 for soft tissue is polymer thin films and versa-tile hydrogel.18 The efficient application of nanomaterialsdepends upon its synthesis routes; however, biologicalroutes are preferred over chemical routes due to cellular,immune, genotoxicity, and carcinogenesis consideration.Newly emerging techniques such as electrophoretic deposi-tion and conventional deposition of biomaterials as nano-layers via self-assembled monolayer, Langmuir–Blodgettfilms, and layer-by-layer assemblies provide precisionin coating at air–water interface.19,20 NP production ofdiverse inorganic materials using colloidal phase, wet lab,and gas phase procedure are other popular conventionalroutes.9,21,22 Among diverse protocols for the NPs produc-tion, gas-phase approaches are very popular due to massproduction via facile scaling route.23–26 These approachesprovide a high level of control on particle physicochemicalproperties such as surface charge, energy, roughness, andporosity with wettability composition.27 In situ synthesis inaerosols and postproduction thermal treatment to improveperformance are other factors attracting this route of metaland oxide NP synthesis. More interesting, surface manipula-tions with a resolution in the 100 nm range and below hasbeen demonstrated using contemporary physical vapor dep-osition (PVD) techniques.28,29
In current review, we present and discuss features ofgas-phase nanocluster production and deposition relevantfor the fabrication of nanostructured systems. In particular,we will discuss the fundamental aspects related with super-sonic cluster beam depositions (SCBDs) for gas phase NPsproduction and possibility of patterning, and coupling toplanar technologies. In last part, we present an overview ofnanostructured thin films in biological applications.
SUPERSONIC CLUSTER BEAM DEPOSITION
Among different gas phase approaches to nanofabrication,the deposition of clusters from supersonic beams is gaining
increased attention extending the interest for this field frombasic to applied research.28 Aggregates ranging from a fewto thousands of atoms called cluster are produced and car-ried in a supersonic regime. Supersonic expansions haveseveral advantages for cluster manipulation over effusivebeams, which make this approach very powerful for thedeposition of nanostructured films. Due to the fact that clus-ter beam depositions favor the manipulation and positioningof NPs by the exploitation of NPs inertial properties, thereis great possibility to couple the SCBD with contemporarymicronanofabrication technologies.29,30
Many theoretical and experimental approaches havebeen developed to solve the problem of neutral NPs manip-ulation in the gas phase.31 The merging of solutions andmodels developed for aerosols, and for supersonic expan-sions has stimulated a novel and interdisciplinary route tosolve this problem.31 The solutions proposed and tested inthe last couple of decades have shown that the synthesis ofnanostructured materials with tailored structural and func-tional properties can be obtained by exploiting aerodynami-cally, focusing on seeded supersonic beams. In particular,the use of aerodynamic lenses32 allows an unprecedentedcontrol on NPs spatial and mass distribution, while keepingvery high fluxes and deposition rates.30 A further improve-ment in aerodynamic manipulation techniques for differentgas phase synthesis methods is opening new perspectivesfor the integration of gas phase NPs production into thelarge and well-consolidated arena of PVD technologies.33
Thanks to the use of collimated beams and stencil masks,patterned depositions with very high lateral resolution canbe obtained. For all these reasons, recently SCBD broughtforth great technological and theoretical interest consideringminimizing the cost/time involved in gas phase NPs produc-tion, manipulation and deposition of nanostructured materi-als using this technique.34,35
The SCBD apparatus houses mainly two chambers: anexpansion (source) chamber and a deposition chamber [seeFig. 1(A); for detail see Ref. 36]. The expansion chamber isequipped with a pulsed microplasma cluster source (PMCS),which represents a combination of different elements typi-cal of sputtering sources, and a laser vaporization clustersource37 as demonstrated in Figure 1(B,C). The clusterdeposition operation principle is based on the three mainevents:
1. The extraction of atoms from a solid sample2. The condensation of the atoms in clusters3. The escaping of the cluster from the source due to the
flow of an inert gas acting as the carrier of clusters.
PMCS and working principleThe group at CIMAINA (Milan, Italy) has developed thePMCS36,37 for the production of nanostructured thin films todeposit many samples in parallel minimizing both time andlabor. It consists of a ceramic cubic body [see Fig. 1(C)] inwhich a cylindrical cavity (of 1.8 cm3 volume) is drilled. Asolenoid-pulsed valve faces one side of the cavity, while theother side is closed by a removable nozzle. A channel
REVIEW ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | OCT 2013 VOL 101A, ISSUE 10 2995
crosses the cavity perpendicularly to its axis and hosts atarget (generally a rod) of the material to be vaporized.Before the valve opening, the cavity has the same pressureof the vacuum chamber that hosts the source (10�6 Torr),while the pressure of the inert gas (helium or argon typi-cally) at the back of the valve is 50 bars. Once the valveopens the large pressure difference causes an adiabaticexpansion which accelerates the gas atoms to overcome thesonic speed, thus, producing a supersonic cluster beam.38
This highly collimated gas jet impacts the rod (the cathode),and after a few microseconds from the valve opening apulsed voltage is applied to the two electrodes (800 V) fora typical duration of few tens of ls. This voltage ionizes theinert gas atoms, producing plasma. Ions are then acceleratedagainst the cathode (by the negative potential) ablating thetitanium rod by sputtering. Since only the gas atoms in theMach disk of the supersonic pulse are ionized,32,39 theplasma is spatially confined. As a result, the cathode rod,which is uniformly rotated during the operation of thesource, is ablated in a well-defined region. The cluster’s con-densation begins immediately after the ablation of the tita-nium atoms in a region very close to the cathode surface.Due to the higher kinetic energy of the sputtered atoms;they expand very rapidly from the hot ablation region, thusshortening the primary aggregation process. As the gas
atoms ionized by the polarization of the electrodes repre-sent only a small fraction of the injected gas (the gas pulselasts near 300 ls, while the voltage pulse is only 60 lslong), and due to the adiabatic cooling of the gas atoms dur-ing the supersonic expansion, the mixture of gas and pri-mary clusters thermalize at a rapid pace.40 In this cold mix-ture, the secondary aggregation takes place. The blend ofcarrier gas and titanium/zirconium clusters can then gradu-ally exit the source cavity through the nozzle, and due tothe high pressure difference between the inside and the out-side of the source, a supersonic expansion of the beamoccurs [see Fig. 1(D–F)].41
In a supersonic jet, the collision rate between the atomsbecomes extremely slow, representing a transition from afluid flow dynamics to a free molecular flow dynamics. Allthe processes based on binary collisions are thereforefrozen, and thus the cluster structures are quenched. Fur-thermore, supersonic beams are much more collimated thaneffusive beams, and offer the opportunity of further decreas-ing their divergence by the nozzle. An aerodynamicallyfocusing assembly consist of five aerodynamic lenses(drilled thin plates) mounted at the end of cylindricalspacers in a sequence [Fig. 1(B)]. This configuration allowsthe clusters to concentrate on the axis of the beam. More-over; this system aerodynamically selects the size of the
FIGURE 1. Schematic of supersonic cluster beam apparatus (A); 3D view of PMCS components working (B) and its internal configuration. PMCS
working principle exhibiting microplasma formation (D), thermalization of nanoclusters (E), and expansion as a supersonic beam (F). [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
2996 SINGH BOTTOM-UP ENGINEERING TO OPTIMIZE CELL–PROTEIN–SURFACE INTERACTIONS
clusters depending on the lens geometry and on the carrier,gas used.32,40 Considering the dimension of the clustermass, there could be three outcomes:
1. If the cluster mass is too big, due to their higher inertiain comparison to the gas atoms, cluster will follow trajec-tories that cause their impact with the focus, preventingexiting from the source.
2. If the mass is too small, the clusters will substantially fol-low the gas streamlines and no focusing will happen.
3. For the proper mass range cluster with a diameter closeto a few tens of nanometers, the trajectories will be con-centrated along the beam axis. The mass range is deter-mined by the focus geometry and by the gas pressure inthe cavity.
As shown in Figure 1(D,E), at step D, ablation of a tita-nium rod takes place by an argon plasma jet, ignited by apulsed electric discharge. After the ablation, TiO2 (or anyother metal oxide) ions thermalize with argon and condenseto form clusters. The mixture of clusters and inert gas isthen extracted in the vacuum through a nozzle to form aseeded supersonic beam, which is collected on a physicalsubstrate located in the beam trajectory. The use of super-sonic beams of clusters allows an excellent control of thecluster mass distribution and kinetic energy with the possi-bility to obtain a highly collimated beam (due to aerody-namically focusing assembly) and very high depositionrates.31,42 The mass range is determined by the focalizer ge-ometry and by the gas pressure in the cavity. Exploitingsimple aerodynamic effects, one can control the divergenceof the supersonic beam and the mass distribution of theparticles.31,43 The size of the exiting nanoclusters dependson the lens geometry and on the carrier gas used. Simply,using stencil masks, patterned films with very high lateralresolutions can be obtained, and this makes SCBD compati-ble with the other planar microtechnologies.42 In a super-sonic jet, the collision rate between the atoms becomesextremely slow, representing a transition from fluid flowdynamics to free molecular flow dynamics. All the processesbased on binary collisions are therefore frozen, and thus thecluster structures are quenched. This allows a low-energyrandom stacking of NPs on the substrate: the particles donot suffer significant fragmentation at the impact, and there-fore, the resulting film keeps memory of the precursorclusters, hence this kind of material is also referred to as acluster assembly. Therefore, SCBD consists in a randomstacking of NPs that leads to materials characterized by alower density with respect to the one shown by filmsobtained from highly energetic particles.34
PMCS-SCBD as an innovative toolto produce ns-TiO2 filmsThe control of film nanotopography and coexisting capabil-ities to regulate physicochemical properties can openstimulating perspectives for applications in surface coatingin biomedicine.
Recently, we have demonstrated that bacterial coloniza-tion on biomaterial surface can be successfully controlled
by tuning the surface nanotopography using SCBD tech-nique.44 Moreover, facile operation and ambient depositionconditions in SCBD make it technology of choice not onlyfor thin film coating [Fig. 2(A–H), left panel] but also inte-grate contemporary micronanofabrication approaches, suchas colloidal lithography [Fig. 2(I–Q), right panel].45 Albeitcomplex, objects characterized at different scales anddimensions are hierarchically organized in biological sys-tems.44 The study of nanostructured titanium oxide (ns-TiO2) thin films production using argon as carrier gas beganapproximately 10 years ago. Cluster-assembled ns-TiO2 filmshave a semiconducting behavior that was initially studiedfor application in catalysis and sensors.30,45–47 Recently, webegan to study and to use ns-TiO2 thin films as a substratefor biological applications because it is possible to use themwith optical instruments, like phase contrast microscopy orconfocal microscopy,48,49 since ns-TiO2 argon thin films areoptically transparent with an estimated refraction index of1.7.50 Also ns-TiO2 thin films have structure constituted bynanocrystals embedded in an amorphous material whichshow good adhesion on various substrates (e.g., glass, mica,and polymer). It is an important parameter for the evalua-tion of the successful performance of cluster-assembledcoatings for various technical and technological applica-tions.51,52 Through the use of a device manipulator and ras-tering, it is possible to produce films whose thickness andcharacteristics are uniform over an extended area, by slidingthe substrate in the plane perpendicular to the beam. Weobtain, on micro- to nanometer scale uniform layer ofns-TiO2 in which grain features are the result of growthdynamics, which follow a ballistic aggregation process, typi-cal of low mobility deposition regimes, provided by lowenergy deposition on cold substrates.30,53
Physical and chemical properties of the clusterassembled filmsAtomic force microscopic (AFM) images of a cluster-assembled TiO2 (left panel) films with nanoscale roughnessare shown in Figure 2(A–H). At the nanoscale, both thefilms expose a granular surface with a grain diameter rang-ing from few up to 20 nm mimicking to that of extracellularmatrix (ECM). This is the result of ballistic deposition ofsize-dispersed clusters, which impinge on the surface andstick together. The cluster growth mechanism leads to ahighly porous material, with a large specific area and asmall average surface slope despite the large surfaceroughness.54
The nanostructure is characterized by nanocrystallineregions embedded in an amorphous matrix. The nanograinsare randomly assembled to constitute a porous structuresuch as those typical of the ballistic aggregation regime, thedensity of the films being roughly half of the correspondingbulk phase (2.5–2.7 g/cm3 against 3.9–4.3 g/cm3 for bulkTiO2). As reported in previous works49 the surface of anas-deposited cluster assembled TiOx is characterized by aremarkable abundance of Ti-3d defect states in the bandgap related to surfacing oxygen vacancies and under coordi-nated titanium atoms.55 These states are known to favor the
REVIEW ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | OCT 2013 VOL 101A, ISSUE 10 2997
dissociative adsorption of water molecules and to play arole in the chemisorptions of a variety of organic mole-cules.56–58 Despite the mean clusters’ diameter, nanostruc-tured films are actually comparable with the thickness ofthe native oxide film grown on pure titanium,55,58 as the de-posited cluster assembled titania exhibit a surface muchmore under-stoichiometric (TiOx). However, post depositionannealing in a dry air reveals surface stoichiometric strictlyclose to MO2 for inorganic materials such as zirconium andtitanium (M: Ti/Zr).59,60
Biotechnological application of nanostructuredthin filmsBiocompatible substrate for primary, cancerous cell cul-ture, and stem cell expansion. Referring to biocompatibil-ity of inorganic and polymeric materials, over the years,many definitions have been offered, nevertheless, updated
manifesto and biocompatibility definition for the 21st cen-tury smart biomaterials, as stated by Prof. BD Ratner ‘‘Bio-compatibility refers to the ability of a material to locallytrigger and guide non-fibrotic wound healing, reconstructionand tissue integration’’.61 In true clinical in vivo set up, it fol-lows that biocompatibility is not just a property of the ma-terial, but it implies the interaction between the materialand the host relatively to a precise function.61,62 This inter-action is strictly connected to the protein-adsorption pro-cess, as cells or any other biomolecules never interactdirectly with the surface. Indeed, as soon as a biomaterialsurface comes into contact with blood, serum or any otherbiological fluid, it is immediately covered by proteins thatform an adsorbed layer. In other words, the interactionbetween a material and the biological environment is medi-ated by the protein adsorption process.58,63,64 More relevantliterature explaining the role of nanostructured surfaces in
FIGURE 2. Cluster beam deposition as a tool for controlled synthesis of nanostructured thin films deposition (left panel) and integrating it with
contemporary planar technologies (right panel). (A–D) Representative height maps in three-dimensional view of ns-TiO2 films produced by
SCBD with increasing thickness (50, 100, 200, and 300 nm)44; (E–H) representative surface profiles exhibiting variations in root mean square
roughness (Rq), specific area (Aspec), correlation length, skewness, and kurtosis, as well as in pore width and depth distributions, as discussed
in the main text. (I–Q) Schematic presentation of the different steps of the NSL-SCBD-based micro- and nanopatterning.45 (J) Glass cover slip as
the starting substrate. (J) Drop-coated FITC-BSA (green) and spin-coated polystyrene microspheres (light blue); the microspheres form a closely
packed hexagonal lattice. (K) ns-TiO2 coating over microspheres obtained by SCBD (yellow). (L) ns-TiO2 micro/nanopatterns generated by soni-
cation in DI. (M) Plating of bacterial cells limits the bacterial interaction with nanotriangles. Right panel (N): AFM image of micro/nanopatterns
of ns-TiO2 þ BSA obtained with 3 lm microspheres (60 lm � 60 lm). (O) Magnified topographic image of (P) showing hexagonal distribution of
triangular nanopatterns (ns-TiO2; 15 lm � 15 lm; z scale: 50 nm). (Q) Magnified image of the ns-TiO2 triangle inside the encircled area of image
(G) showing granular morphology of ns-TiO2 (500 nm � 500 nm; z scale: 50 nm). (D) Overlay of reflectance and fluorescence images showing
both the reflective ns-TiO2 islands and the precoated FITC-BSA underneath, visible as the green fluorescent signal (scale bar: 10 lm). [Color fig-
ure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
2998 SINGH BOTTOM-UP ENGINEERING TO OPTIMIZE CELL–PROTEIN–SURFACE INTERACTIONS
proteins and biointerfacial interactions which are beyondthe scope of this review can be found elsewhere.65,66
A recent work characterized the biocompatibility of ns-TiOx films produced by the deposition of a supersonic beamof TiOx clusters via analyzing different interactions (van derWaals, electrostatic, and chemical bonding) between AFMtip and surface.53 The findings corroborate past andcurrent cellular studies showing the new material is highlybiocompatible, and it supports normal growth and adhesionof immortalized, tumor and primary cells, and stemcells without coating with ECM proteins (Fig. 3).41,67,68
Therefore, ns-TiOx is proposed as an optimal substrate fordifferent applications in cell-based assays (cell microarray),biosensors, or microfabricated devices for medical applica-tions69–72 (Table I). The size of the clusters composing thens-TiOx film as well the size of many ECM proteins is of theorder of a few nanometers. As an immediate implication, ona sufficiently small scale (i.e., few hundreds of nanometers)the surface morphology of cluster-assembled ns-TiOx canmimic the natural ECM environment. This topography pro-vides a synthetic cue for ECM protein adsorption from cellculture media, thus, generating biochemical cue with correctorientation and clustering of integrin proteins, promotingcell–ECM interaction.
Given that the topographic features of the substrate playan essential role, the morphology of the cluster assembledns-TiOx may favor the interaction of cells with its surface.48
Therefore, it is of extreme interest to quantitatively charac-terize the interaction of this new material with proteins, asthis is the basis for controlling cell–surface interactions.67
Considering our recent study on nanostructured zirconiumoxide, to the best of our knowledge, bottom-up approach ofzirconia film synthesis in form of nanoclusters, using PMCStechnique is truly novel with defined nanoscale physical andchemical properties.9 The nanoscale morphology and sur-face topography of zirconia shares much similarity with thetitania except surface chemistry. Titanium oxides films haveversatile chemistry as described in above sections, whereaszirconium oxide behaves like almost bioinert surfaces.Human osteosarcoma cell line (MG-63) and Pheochromocy-toma (PC12) cell lines seeded on the cubic ns-ZrOx filmsmade by the bottom-up approach demonstrated precisesensing of nanoscale roughness of different zirconia filmswith increasing focal adhesion complex formation (Fig. 4).9
Application of nanostructured film in designing cell andprotein microarray. Living-cell microarrays are powerfultools for functional genomics and drug discovery.70–72 Inthis perspective, new approaches have been proposed tophenotype screening through the creation of living-cellmicroarrays, which exploit the ‘‘reverse transfection’’ of com-plementary DNAs or small interfering RNAs or the ‘‘reverseinfection’’ by lentiviral vectors to allow the simultaneoushigh-throughput analysis of the function of many differentgenes on a glass slide.71,73,74 However, despite severalattempts to improve this technology, it is still a challenge toobtain microarrays of cells with competence to overexpress-ing or downregulating specific genes to address complex
phenotypes.75–77 The bottleneck of technology relies in effi-cient immobilization of molecule of interest on a putativesurface, exhibiting correct functional state to be expressedin living cells.78–80 Other than this, there is a need of experi-mental protocols to fabricate substrate topography andchemistry on an artificial substrates which ‘‘mimic’’ theextracellular environment surrounding cells in vivo, likely topresent more appropriate physiological cues to culturedcells.81,82 In this regard, researchers immobilized viral vec-tors on a ns-TiO2 film obtained by depositing a supersonicbeam of titania clusters on a glass substrate. The SCBD-based technique demonstrated the validation of the retrovi-ral cell array by overexpression of green fluorescent protein(GFP) reporter genes in primary and cancer cells, and byRNA interference of p53 in primary cells by analyzingeffects in cell growth (Fig. 5). It has been demonstrated thatns-TiO2 retroviral arrays are an enabling tool for the studyof gene function of families of genes for complex pheno-types and for the identification of novel drug target.83
After the successful completion of the Human GenomeProject, the researchers involved in Human Proteome Orga-nization are looking forward in exploring a global HumanProteome Project, which is designed to map the entirehuman protein set (proteome).84 However, analysis of pro-tein expression and functions of human proteome data baseavailable has revealed there is tremendous complexity andvariability involved in the individual amino acids in proteinsequences.85,86 This inherent complexity of the human pro-teome has encouraged the development of sophisticatedmultiplexed technologies for more appropriate methods ofanalysis. As a consequence, the trend of detection technolo-gies has moved from low-throughput analytical methodsuch as enzyme-linked immunosorbent assay, Western blotto ‘‘high-content/high-throughput’’ approaches.87 In this con-text, the development of novel high throughput miniaturizeddevices, such as biochips and microarrays, can offer a validapproach to interrogate the high content proteome by multi-plexing the information at a reasonable cost.87,88 Due to thisfact, other than living cell microarray, protein microarraytechnologies are rapidly expanding to fulfill current needsof proteome discovery for disease management.87,89,90
As explained in the previous sections, ns-TiOx surface ischaracterized by morphology at the nanoscale that can betuned to modulate specific biomolecule–material interactions.58
It is important to note that topographical features withdimensions similar to the surface bound biomolecule (�10nm) can significantly affect their morphology and activityfor cell–surface interactions.56,91 Carbone et al.50 presenteda systematic characterization of ns-TiOx coatings as proteinbinding surfaces for antibody microarray using SCBD pro-duced nanostructured film. Comparing the performances ofthe coating with those of the most common commercialsubstrates in protein and antibody microarray assays, thismethod demonstrated equivalent efficiency. Through a ro-bust statistical evaluation of repeatability in terms of coeffi-cient of variation analysis, they demonstrate that ns-TiOxcan be used as a reliable substrate for biochips in analyticalprotein microarray application.48
REVIEW ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | OCT 2013 VOL 101A, ISSUE 10 2999
FIGURE 3. Immunofluorescence analysis of cytoskeleton and cellular adhesion markers on gelatin- and cluster-assembled nanostructured (ns)
TiO2-coated coverslips at short and long-term points. (A) MEFs, (B) Tig3-hTert, (C) U2OS, and (D) human primary melanocytes (small arrows
identify ‘‘long’’ and big arrows identify ‘‘short’’ focal adhesions). (E–G) In vitro endothelial differentiation of human circulating CD133Þ cells after
expansion on cluster-assembled ns-TiO2 layers and control condition, performed in coculture with a line of human umbilical vein endothelial
cells (HUVEC), used also as a positive control. 2 h after deposition, CD133Þ cells still can be distinguished from HUVEC cells used as feeder (A);
after 14 days of coculture, CD133Þ cells appear as endothelial structures and adherent mature endothelial cells CD31Þ (red) (B). Endothelial
marker expression has been verified through reverse transcriptase polymerase chain reaction analysis (C), both for CD133Þ cells previously
expanded on cluster-assembled ns-TiO2 layers (1, as-deposited; 2, annealed at 400�C) and in control conditions. (Reproduced with permission
from Refs. 51, 68.) [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
3000 SINGH BOTTOM-UP ENGINEERING TO OPTIMIZE CELL–PROTEIN–SURFACE INTERACTIONS
TA
BLE
I.A
pp
licati
on
of
Nan
ost
ruct
ure
dFilm
sin
Bio
med
icin
eP
rod
uced
by
Clu
ste
rB
eam
Dep
osit
ion
Bio
tech
no
log
yA
pp
lica
tio
ns
SC
BDþ
PM
CS
Inte
gra
ted
wit
hC
on
tem
po
rary
Tech
niq
ue
Co
mp
ati
bilit
yw
ith
Pla
nar
Mic
roN
an
ofa
bri
cati
on
Tech
niq
ue
Un
derl
yin
gM
ech
an
ism
Rem
ark
Refe
ren
ce
Nan
ost
ruct
ura
tio
no
fm
icro
devic
eC
ollo
idal
lith
og
rap
hy
(NS
L)
an
dS
CB
DY
es
Mic
rosp
here
mo
no
layer
use
das
mask
for
nan
op
att
ern
ing
of
TiO
xS
trate
gy
cou
ldb
eu
sefu
lto
pro
mo
tem
am
malian
cells
an
din
hib
its
bact
eri
al
colo
niz
ati
on
inin
viv
op
rost
heti
cd
evic
es
45
SC
BDþ
e-b
eam
lith
og
rap
hy
an
dlift
off
Yes
Faci
lep
roto
col
of
mic
ron
an
ofa
bri
cati
on
via
lift
off
pro
ced
ure
ino
rgan
icso
lven
tS
pati
al
con
tro
lo
fce
llad
hesi
on
(PC
12)
over
mic
rod
evic
e63
SC
BDþ
collo
idal
lith
og
rap
hy
Yes
Mic
ron
an
op
att
ern
ing
of
top
og
rap
hic
(TiO
x)
an
dch
em
ical
cues
(BS
A)
Pro
toco
lp
erm
its
toco
ntr
ol
com
ple
xce
llfu
nct
ion
such
as
dif
fere
nti
ati
on
sca
nb
ein
du
ced
64
Invit
rom
od
el
for
pro
kary
oti
cce
ll-
nan
ost
ruct
ure
dti
tan
iaco
mm
un
icati
on
SC
BDþ
PM
CS
NA
Bact
eri
al
ad
hesi
on
isco
ntr
olled
by
ns-
TiO
xfi
lmro
ug
hn
ess
Stu
dy
dem
on
stra
tes
qu
an
tifi
cati
on
of
bact
eri
al–
cell
surf
ace
inte
ract
ion
s44
Bio
com
pati
ble
coati
ng
for
stem
cell
bio
log
yS
CB
Dþ
PM
CS
NA
Hu
man
circ
ula
tin
gm
yo
gen
icp
rog
en
ito
rssh
ow
invit
roca
paci
tyto
dif
fere
nti
ate
into
myo
gen
icce
lls
Po
ten
tial
for
stem
cell
exp
an
sio
nan
dd
iffe
ren
tiati
on
inn
clin
ical
set
up
68
Bio
com
pati
ble
coati
ng
for
pri
mary
an
dca
nce
rce
llcu
ltu
re
SC
BDþ
PM
CS
NA
Exce
llen
tp
latf
orm
for
cell
cult
ure
surf
ace
coati
ng
w/o
mo
difi
cati
on
wit
hE
CM
pro
tein
s
clu
ster-
ass
em
ble
dT
iOx
pro
mo
tes
ad
sorp
tio
nan
dst
ab
ilit
yo
fE
CM
pro
tein
41
Pro
tein
–su
rface
inte
ract
ion
mic
roarr
ay
(PS
IM)
SC
BDþ
PM
CSþ
inkj
et
pri
nti
ng
Yes
Nan
om
ete
r-sc
ale
mo
rph
olo
gy
on
reg
ula
tes
pro
tein
ad
sorp
tio
no
nm
ate
rial
oxid
esu
rface
s
qu
an
tita
tive
hig
h-t
hro
ug
hp
ut
chara
cteri
zati
on
of
pro
tein
–su
rface
inte
ract
ion
67
Pro
tein
an
dan
tib
od
ym
icro
arr
ay
Nan
ocl
ust
er
of
TiO
2Y
es
An
tib
od
yad
sorp
tio
nw
ith
corr
ect
fold
ing
an
dep
ito
pe
exp
ress
ion
Co
mm
erc
ial
bio
chip
sin
an
aly
tica
lp
rote
inm
icro
arr
ay
50
Flu
ore
scen
cein
situ
hyb
rid
izati
on
(FIS
H)
mic
roch
ip
Mic
rofl
uid
icin
teg
rate
dw
ith
nan
ocl
ust
ers
of
TiO
2
Yes
Nan
om
ate
rial
pro
mo
tes
hem
ato
po
ieti
cce
llim
mo
biliz
ati
on
inco
nd
itio
ns
of
shear
stre
ss
Mic
rofl
uid
ic-b
ase
dsc
reen
ing
chro
mo
som
al
ab
err
ati
on
sin
can
cer
114
Retr
ovir
al
mic
roarr
ay-
base
dp
latf
orm
Mic
rosp
ott
ing
inte
gra
ted
wit
hS
CB
DY
es
Retr
ovir
al
arr
ay
over
exp
ress
ion
ind
iffe
ren
tce
lllin
es
over
TiO
2-c
oate
dst
rep
tavid
in
Cell-b
ase
dm
icro
arr
ay
for
ph
en
oty
pe
scre
en
ing
84
Bo
tto
m-u
pen
gin
eeri
ng
of
zirc
on
ium
oxid
eth
infi
lms
Clu
ster
beam
-dep
osi
ted
zirc
on
iaY
es
Ns-
ZrO
x-c
oate
dfi
lms
dem
on
stra
teexce
llen
tb
ioco
mp
ati
bilit
yag
ain
std
iffe
ren
tce
lllin
es
Po
ten
tial
for
ad
van
ceap
plica
tio
ns
ind
en
tist
ry9
Cell
ad
hesi
on
an
dp
rolife
rati
on
Nan
ost
ruct
ure
dca
rbo
nfi
lms
Yes
Su
rface
mo
rph
olo
gy
pla
ys
vit
al
role
inca
rbo
n–c
ell
inte
ract
ion
Nan
ost
ruct
ure
dca
rbo
nco
uld
be
use
das
next
gen
era
tio
nce
llcu
ltu
resu
bst
rate
115
An
tib
od
yp
uri
fica
tio
n-
ind
ep
en
den
tm
icro
arr
ays
(PIM
)
Tit
an
iafi
lms
Yes
Dir
ect
bact
eri
al
cell
spo
ttin
go
nT
iO2
coate
dsl
ides
Vari
ab
led
om
ain
so
fsi
ng
leh
eavy-c
hain
an
tib
od
ies
ag
ain
stfi
bro
bla
stg
row
thfa
cto
r28
rece
pto
r1
(FG
FR
1)
were
use
dto
cap
ture
the
an
tig
en
106
Inviv
osi
mu
lati
on
of
bact
eri
a–
nan
ost
ruct
ure
dsu
rface
inte
ract
ion
PM
CS
-dep
osi
ted
thin
film
Yes
Bact
eri
ase
nse
nan
osc
ale
rou
gh
ness
wit
hu
ltra
pre
cisi
on
Invit
rost
ud
yd
em
on
stra
tes
nan
osc
ale
rou
gh
ness
cou
ldb
eu
sed
toco
ntr
ol
bact
eri
al
cell
colo
niz
ati
on
on
imp
lan
tsu
rface
116
REVIEW ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | OCT 2013 VOL 101A, ISSUE 10 3001
Immunocell arrays technology based on antibody–nanostructured surface interaction. The knowledge of sig-naling pathways, which are triggered by physiological andpathological conditions or drug treatment, is essential for thecomprehension of the biological events that regulate cellularresponses.92,93 Recently novel platforms based on ‘‘Reverse-Phase Protein Arrays or Reverse Phase Protein Microarray(RPMA)’’ have proven to be useful in the study of differentpathways.94 However, it still lack the possibility to detectevents in the complexity of a cellular context.95,96 RPMA istechnically efficient in analyzing any fluid from cellularlysates or body fluids (serum, cerebrospinal fluid, urine, vit-reous, saliva, etc.) printed with micro- or nanospotter anddetected by secondary labeled antibody via chemilumines-cent, fluorescent or colorimetric assays. Unlike conventionalprotein array which are preferably designed with microscaleddot-blot platforms, RPMA utilizes either of the micro- ornanoscaled dot-blot platform which allows measurement ofprotein expression.97 The advantage of RPMA technologyover its contemporary counterparts is that it provides high
dimensional proteomic data in a high throughput, sensitiveand quantitative manner. An efficient modified version ofRPMA is immune cell array for multiplexed analysis of signal-ing pathways in drug response screening. An ‘‘immunocell-array’’ of cells on chip was developed using ns-TiOx as novelcoating substrate, where upon cell plating, culture, drugtreatment, and fixation, by spotting specific antibodies (Fig.6).98 On the chip, one can detect the localization and state ofhundreds of proteins involved in specific signaling pathways.By applying this technology to mammalian cells, the group atTethis s.r.l. analyzed signaling proteins involved in theresponse to DNA damage and identified a chromatin remod-eling pathway following bleomycin treatment.99 The technol-ogy developed manifests a new tool for the array-based mul-tiplexed analysis of signaling pathways in drug responsescreening.100 It also applies to the proteomics of profilingpatient cells, and ultimately for the high-throughput screen-ing of antibodies for immunofluorescence application.101,102
The conational microarray platforms utilizes surfacecoating to immobilize protein/peptide/antibody in chip
FIGURE 4. Zirconium oxide as novel coating for cell culture substrate. (A–F) Fluorescent immune labeling of adhesion complexes and stress
fiber organization of the Pheochromocytoma (PC12) cell line on nanostructured ZrOx films. PC12 cultured on ns-ZrOx (50–100–200 nm) sub-
strates formed well-organized stress fiber and numerous premature (large arrows) and mature adhesions (small arrows). (G–L) MG-63 cells.
Adhesions plaques were numerous and located predominantly at the cell periphery. (A, C, and E) cell clusters and an individual [squared cell
from cluster, (B, D, and F)] magnified (4�) view of PC12 cell. Similarly, (G, I, and K) MG-63 cell cluster and magnified (H, J, and L) view.9 [Color
figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
3002 SINGH BOTTOM-UP ENGINEERING TO OPTIMIZE CELL–PROTEIN–SURFACE INTERACTIONS
format with correct accessibility of the antibody active moi-eties or functional groups involved in complementary reac-tion. On the other hand, immobilizing whole cells on bio-compatible metal/metal oxide coated substrate expressingantibodies to capture antigen could be more productive inpreparing sensitive and specific microarrays for antigendetection. In a similar approach, nanostructured thin filmswere used for spotting bacteria that expose recombinantantibodies on their external surface directly on nanostruc-tured-TiO2 or epoxy slides [purification-independent micro-array (PIM)]. This is a simple and reliable alternative forpreparing sensitive and specific microarrays for antigendetection. Variable domains of single heavy-chain antibodiesagainst fibroblast growth factor receptor 1 (FGFR1) wereused to capture the antigen diluted in serum or bovine se-rum albumin (BSA) solution.103–106 The FGFR1 detectionwas performed by either direct antigen labeling or using asandwich system in which FGFR1 was first bound to itsantibody and successively identified using a labeled FGF. Inboth cases, the signal distribution within each spot was uni-
form and spot morphology regular. The signal-to-noise(S/N) ratio was extremely elevated, and the specificity ofthe system was proven statistically.104 The level of detectionof the system for the antigen was calculated being 0.4ng/mL and the dynamic range between 0.4 ng/mL and 10lg/mL. The microarrays prepared with bacteria exposingantibodies remain fully functional for at least 31 days afterspotting on the ns-TiO2 films. The current method is suita-ble for other antigens–antibody pairs and expects that itcould be easily adapted to further applications such as thedisplay of scFv and IgG antibodies or the autoantibodydetection using protein PIMs.106
Protein–surface interaction microarrays. Protein surfaceinteractions is the first of complex cascade of events regu-lates many phenomena at the nanobiointerface such asin vivo inflammatory responses, cell adhesion and differen-tiation on synthetic surfaces in vitro. Protein surface interac-tion microarray (PSIM) is a powerful method for studyingin details the interaction between proteins and
FIGURE 5. Retroviral microarrays for the overexpression of Enhanced Green Fluorescent Protein-EGFP-fused proteins; (A) 10� immunofluores-
cence panel of a 10 � 24 arrays of MCF10A cells infected by PINCO and PINCO GFP-NPM vectors in an alternate fashion. Colors as in panel (A)
blue, cell nuclei (DAPI staining); green, GFP fluorescence. (B) 20� magnification of fields from spots in a selected area of the array; GFP fluores-
cence only is shown. (C) 10� immunofluorescence panel of a 12 � 24 arrays of U2OS cells infected by the same vectors in an alternate fashion.
(D) 20� magnification of fields from spots in a selected area of the U2OS array; GFP fluorescence only is shown. (E) Scatter plots of GFP inten-
sity versus DAPI intensity in populations infected by PINCO (blue) and PINCO GFP-NPM (red) in MCF10A cells. The percentage of infected cells
is reported. (F) Same as the panel (E) for U2OS cells (Printed with permission Ref. 84). [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
REVIEW ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | OCT 2013 VOL 101A, ISSUE 10 3003
nanostructured surfaces considering relevance of the media-tion adsorbed protein in biomaterial–cell interac-tions.12,67,106,107 PSIM is based on protein array technology,and it allows to study in one single experiment hundreds ofdifferent protein surface interactions. PSIM protocol consistsin spotting small-volume droplets (30 nL) of fluorescent-labeled proteins on the surface under investigation[Fig. 7(A)]. After incubation, blocking, washing, and drying,the amount of adsorbed proteins is evaluated by readingthe fluorescent signal with a commercial microarray scan-ner108 [Fig. 7(B)]. Using PSIM it is possible to compare, onthe same biomaterial sample, the amount of adsorbed pro-teins for a panel of proteins under various conditions suchas protein concentration and pH.109 Since the experimentcan be performed in parallel on several biomaterial samples,PSIM allows characterizing the role of surface synthesis pa-rameters in protein immobilization. PSIM is applicable tomany nanostructured surfaces, and it is a very flexiblemethod, in each of the 300 drops that can be spotted on aglass slide (25 mm � 75 mm), it is possible to change pro-
tein concentration, pH, buffer, salt concentration or proteintype. New spotting technologies give the possibility to study1200 different protein surface interactions in a singleexperiment. The high number of spots can also be used tomake replicates, and to produce very good statistics foreach interaction.110,111
The recent application of a high-throughput characteriza-tion approach to study the effect of surface nanoscale mor-phology on protein adsorption shed more light on this phe-nomenon. PSIM has been applied to ns-TiOx for carrying outsystematic characterization of the adsorption of proteins onnanostructured surfaces.64,67 With PSIM, it was possible tostudy the adsorption of a panel of three proteins (BSA, fibri-nogen, and streptavidin) on a ns-TiOx library composed byfive families of samples each with different surface morphol-ogy110 [Fig. 7(C–E)]. Thanks to PSIM high-throughput power,it was possible to design an experiment in which 1200 pro-tein–surface interaction were studied in order to reproduceprotein adsorption isotherms for the different proteins [Fig.7(C–E)]. Results confirm that nanoscale morphology signifi-cantly enhances the adsorption of proteins. Varying surfaceroughness from 15 nm to 30 nm, amount of adsorbed pro-teins increases up to 600%, well beyond the correspondingincrease of specific area.111 The application of PSIM, in com-bination with other quantitative methods, demonstrated thatthe increase is related to the formation of protein clusters incorrespondence of surface nanometric pores. The nanometricpores inducing protein clusterization112 are characterized byan aspect ratio higher than a threshold value (depends onthe protein characteristic).67,113
CONCLUDING REMARKS
The SCBD technique provides a cutting-edge solution tocontrol surface texture without changing chemistry (biomo-lecular information) at the biomaterial–tissue interface in aspatially controlled manner, which is greatly compromisedin both contemporary gas and chemical vapor depositiontechnologies. In the present review, we demonstrated thatthe cluster beam depositions technique is a vital tool fornanostructured film production with controlled surface to-pography, without changing surface chemical compositions.The most important property of the clusters produced atnanoscale via SCBD is the ECM mimicking topography,which opens a plethora of applications in biotechnology: anefficient surface coating to the cell culture substrate formammalian as well as prokaryotic (bacterial) cell adhesion.Many cell culture-based biological assay need surface coat-ing by ECM proteins or poly-L-lysine for cell adhesion whichoften alters surface chemistry. This in turn might affect thegenomic and proteomic profile of the cells. In addition, bio-compatibility of ns-TiOx/ZrOx films makes it future technol-ogy for the coating implants surface to promote interactionsof the prosthesis with surrounding tissue/organ in vivo. Theprotein surface interactions make it a valuable tool fordesigning HTP protein microarrays for functional genomicsand drug screening; immunocell array and ECM-based cellarrays. Moreover, SCBD compatibility with the planar tech-nologies makes it the technique of choice for the
FIGURE 6. (A) Mouse IgG spot morphology and background on the
ns-TiOx slide. The excellent morphology is demonstrated by surface
plot (B) and plot profile (C) of a selected 3 � 3 arrays of mouse IgG
spots detected by anti-mouse Cy3 antibody. (D) ns-TiOx slide back-
ground in comparison with epoxy and NC slides. (E) Schematic depic-
tion of the immunocell-array technology. Cells are cultured directly on
slides and processed at the appropriate time for immunostaining, and
images are acquired with an automated fluorescence microscope and
analyzed by imaging software (adopted with permission from Refs.
50,101. [Color figure can be viewed in the online issue, which is avail-
able at wileyonlinelibrary.com.]
3004 SINGH BOTTOM-UP ENGINEERING TO OPTIMIZE CELL–PROTEIN–SURFACE INTERACTIONS
future Bio-MEMS and Bio-NEMS device productions(Table I).114–116 Further exploration should be focused onintegrating SCBD with silicon-based microtechnologies toreach the next level of technological innovations.
ACKNOWLEDGMENTS
We thank for the support from Ahmad Abu-Hakmeh in revisingthe manuscript for syntax, grammatical errors, and specific re-vision to biological part.
REFERENCES
1. Santamaria A. Historical overview of nanotechnology and nano-
toxicology. Methods Mol Biol 2012;926:1–12.
2. Nano-express from New Delhi? Nat Mater 2005;4(8):575.
3. Zhou J, Wu S, Yu T, Xie Z. 2011 International Conference on
Modified Pyrolytic Carbon Black from Scrap Tires and Its Rein-
forcement Performance in Natural Rubber. Computer Distributed
Control and Intelligent Environmental Monitoring (CDCIEM);
2011. p 472–475.
4. Braun JH, Baidins A, Marganski RE. TiO2 pigment technology: A
review. Prog Org Coat 1992;20(2):105–138.
5. Ulrike D. The surface science of titanium dioxide. Surf Sci Rep
2003;48(5–8):53–229.
6. Eran B. In: Eitan S,Shimon U, editors. Combining Top-Down
and Bottom-Up Segmentation; 2004. p 46.
7. Eaton MAW. How do we develop nanopharmaceuticals under
open innovation? Nanomed Nanotechnol Biol Med 2011;7(4):
371–375
8. Neher E. Molecular biology meets microelectronics. Nat Biotech-
nol 2001;19(2):114
9. Singh AV, Ferri M, Tamplenizza M, Borghi F, Divitini G, Ducati C,
Lenardi C, Piazzoni C, Merlini M, Podest�a A, Milani P. Bottom-up
engineering of the surface roughness of nanostructured cubic
zirconia to control cell adhesion. Nanotechnology 2012;23:
475101.
10. Perry JL, Herlihy KP, Napier ME, DeSimone JM. PRINT: A novel
platform toward shape and size specific nanoparticle theranos-
tics. Acc Chem Res 2011;44(10):990–998
11. Mihail CR. Nanotechnology: Convergence with modern biology
and medicine. Curr Opin Biotechnol 2003;14(3):337–346
12. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of bio-
material–cell interactions by adsorbed proteins: A review. Tissue
Eng 2005;11(1–2):1–18.
13. Yarmush ML, King KR. Living-cell microarrays. Annu Rev
Biomed Eng 2009;11(1):235–257
14. Galli C, Collaud Coen M, Hauert R, Katanaev VL, Wymann MP,
Gr€oning P, Schlapbach L. Protein adsorption on topographically
nanostructured titanium. Surf Sci 2001;474(1–3):L180–L184.
15. Singh AV, Vyas V, Montani E, Cartelli D, Parazzoli D, Oldani A,
Zeri G, Orioli E, Gemmati D, Zamboni P. Investigation of in vitro
cytotoxicity of the redox state of ionic iron in neuroblastoma
cells. J Neurosci Rural Pract 2012;3(3):301–310
16. Li J. Nanostructured Biomaterials.New York, NY:Springer; 2010.
p 222.
17. Singh AV, Khare M, Gade WN, Zamboni P. Theranostic implica-
tions of nanotechnology in multiple sclerosis: A future perspec-
tive. Autoimmune Dis 2012;2012:1–12.
18. Vendra VK, Lin Wu, Krishnan S. Polymer Thin Films for Biomedical
Applications.Weinheim, Germany:Wiley-VCH Verlag; 2010. p 54.
19. Boccaccini AR, Keim S, Ma R, Li Y, Zhitomirsky I. Electrophoretic
deposition of biomaterials. J R Soc Interface 2010;7(Suppl 5):
S581–S613.
20. Ariga K, Nakanishi T, Michinobu T. Immobilization of biomateri-
als to nano-assembled films (self-assembled monolayers, Lang-
muir–Blodgett films, and layer-by-layer assemblies) and their
related functions. J Nanosci Nanotechnol 2006;6(8):2278–2301
21. Singh AV, Patil R, Kasture MB, Gade WN, Prasad BL. Synthesis
of Ag–Pt alloy nanoparticles in aqueous bovine serum albumin
foam and their cytocompatibility against human gingival fibro-
blasts. Colloids Surf B: Biointerfaces 2009;69(2):239–245
22. Singh AV, Bandgar BM, Kasture M, Prasad BLV, Sastry M. Syn-
thesis of gold, silver and their alloy nanoparticles using bovine
serum albumin as foaming and stabilizing. J Mater Chem 2005;
15(48):5115–5121
FIGURE 7. Sketch of the six steps PSIM protocol. The proposed method verified the feasibility of this approach with specific assays and demon-
strated that the fluorescent signal is proportional to the amount of adsorbed proteins and that the fluorescent marker used in the experiment
does not influence the protein–surface interaction process. Finally, using fluorescence recovery after photobleaching (FRAP), it is also verified
that the adsorbed proteins remain immobilized on the surface after adsorption. (B) Raw data obtained by reading the slides of the PSIM experi-
ment in which eight concentrations of BSA, fibrinogen and streptavidin were spotted in 10 replicates on the five nanostructured titania samples,
with different surface morphology. (C) adsorbed fibrinogen, (D) BSA, and (e) streptavidin as a function of protein concentration (adsorption iso-
therms) for five ns-TiOx samples with different surface roughness. PSIM allowed obtaining adsorption isotherms on nanostructured surfaces for
the first time. Data are fitted with Langmuir isotherm in order to calculate saturation uptake and binding affinity. Error bars correspond to stand-
ard deviation of the 10 replicates (Ref. 67). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
REVIEW ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | OCT 2013 VOL 101A, ISSUE 10 3005
23. Stark WJ, Pratsinis SE. Aerosol flame reactors for manufacture
of nanoparticles. Powder Technol 2002;126(2):103–108
24. Wegner K, Pratsinis SE. Scale-up of nanoparticle synthesis in dif-
fusion flame reactors. Chem Eng Sci 2003;58(20):4581–4589
25. Kammler HK, M€adler L, Pratsinis SE. Flame synthesis of nano-
particles. Chem Eng Technol 2001;24(6):583–596
26. Singh Y, Javier RN, Ehrman SH, Magnusson MH, Deppert K.
Approaches to increasing yield in evaporation/condensation
nanoparticle generation. J Aerosol Sci 2002;33(9):1309–1325
27. Wegner K, Pratsinis SE. Nozzle-quenching process for controlled
flame synthesis of titania nanoparticles. AIChE J 2003;49(7)
1667–1675
28. Milani P, Barborini E, Piseri P, Bottani CE, Ferrari AC, Li Bassi A.
Nanostructured carbon films from supersonic cluster beam dep-
osition: Structure and morphology. Eur Phy J D 1999;9(1):63–68
29. Milani P, Piseri P, Barborini E, Podesta A, Lenardi C. Cluster
beam synthesis of nanostructured thin films. J Vac Sci Technol
2001;19(4):2025–2033
30. Mazza T, Barborini E, Kholmanov IN, Piseri P, Bongiorno G,
Vinati S, Milani P, Ducati C, Cattaneo D, Li Bassi A, Bottani CE,
Taurino AM, Siciliano P. Libraries of cluster-assembled titania
films for chemical sensing. Appl Phys Lett 2005;87:103108.
31. Piseri P, Podesta A, Barborini E, Milani P. Production and charac-
terization of highly intense and collimated cluster beams by iner-
tial focusing in supersonic expansions. Rev Sci Instrum 2001;
72(5):2261–2267
32. Tafreshi HV, Piseri P, Benedek G, Milani P. The role of gas dy-
namics in operation conditions of a pulsed microplasma cluster
source for nanostructured thin films deposition. J Nanosci Nano-
technol 2006;6:1140–1149.
33. Mazza T, Barborini E, Kholmanov IN, Piseri P, Bongiorno G,
Vinati S, MIlani P, Ducati C, Li Bassi A, Bottani CE, Taurino AM,
Siciliano P. Libraries of cluster-assembled titania films for chemi-
cal sensing. Appl Phys Lett 2005;87(10).
34. Wegner K, Piseri P, Tafreshi V, Milani P. Cluster beam deposi-
tion: A tool for nanoscale science and technology. J Phys D:
Appl Phys 2006;39(22):R439–R459.
35. Chiappini C, Piseri P, Vinati S, Milani P. Supersonic cluster beam
deposition of nanostructured thin films with uniform thickness
via continuously graded exposure control. Rev Sci Instrum 2007;
78(6).
36. Barborini E, Piseri P, Milani P. A pulsed microplasma source of
high intensity supersonic carbon cluster beams. J Phys D: Appl
Phys 1999;32:L105.
37. Barborini E, Piseri P, Milani P. A pulsed microplasma source of
high intensity supersonic carbon cluster beams. J Phys D: Appl
Phys 1999;32:L105–L109.
38. Andersen N. In: Scoles G, editor. Atomic and Molecular Beam
Methods, Vol. 1. New York, NY and Oxford, UK: Oxford Univer-
sity Press; 1988. p 206–207.
39. Barborini E, Piseri P, Li Bassi A, Ferrari AC, Bottani CE, Milani P.
Synthesis of carbon films with controlled nanostructure by sepa-
ration of neutral clusters in supersonic beams. Chem Phys Lett
1999;300(5):633–638
40. Tafreshi HV, Benedek G, Piseri P, Vinati S, Barborini E, Milani P.
A simple nozzle configuration for the production of low diver-
gence supersonic cluster beam by aerodynamic focusing. Aero-
sol Sci Technol 2002;36(5):593–606
41. Milani P, Piseri P, Barborini E, Podesta A, Lenardi C. Cluster
beam synthesis of nanostructured thin films. J Vac Sci Technol
A: Vac Surf Films 2001;19:2025.
42. Barborini E, Piseri P, Podesta A, Milani P. Cluster beam micro-
fabrication of patterns of three-dimensional nanostructured
objects. Appl Phys Lett 2000;77(7):1059–1061
43. Piseri P, Tafreshi HV, Milani P. Manipulation of nanoparticles in
supersonic beams for the production of nanostructured materi-
als. Curr Opin Solid State Mater Sci8:195–202.
44. Singh AV, Vyas V, Patil R, Sharma V, Scopelliti PE, Bongiorno G,
Podest�a A, Lenardi C, Gade WN, Milani P. Quantitative character-
ization of the influence of the nanoscale morphology of nano-
structured surfaces on bacterial adhesion and biofilm formation.
PLoS One 2011;6(9):e25029.
45. Singh AV, Salve TS, Cortelli D, Dellasega D, Podesta A, Milani P,
Gade WN. Biofilm formation on nanostructured titanium oxide
surfaces and a micro/nanofabrication-based preventive strategy
using colloidal lithography. Biofabrication 2012;4(3).
46. Fioretti F, Mendoza-Palomares C, Helms M, Al Alam D, Richert
L, Arntz Y, Rinckenbach S, Garnier F, Haıkel Y, Gangloff SC,
Benkirane-Jessel N. Nanostructured assemblies for dental
application. ACS Nano 2010;4(6):3277–3287
47. Barborini E, Vinati S, Leccardi M, Repetto P, Bertolini G, Rorato
O, Lorenzelli L, Decarli M, Guarnieri V, Ducati C, Milani P. Batch
fabrication of metal oxide sensors on micro-hotplates. J Micro-
mech Microeng 2008;18:7.
48. Cassina V, Gerosa L, Podest�a A, Ferrari G, Sampietro M, Fioren-
tini F, Mazza T, Lenardi C, Milani P. Nanoscale electrical proper-
ties of cluster-assembled palladium oxide thin films. Phys Rev B
2009;79(11):115422
49. Della Foglia F, Losco T, Piseri P, Milani P, Selli E. Photocatalytic
activity of nanostructured TiO2 films produced by supersonic
cluster beam deposition. J Nanopart Res 2009;11(6):1339–1348
50. Carbone R, De Marni M, Zanardi A, Vinati S, Barborini E, Forna-
sari L, Milani P. Characterization of cluster-assembled nanostruc-
tured titanium oxide coatings as substrates for protein arrays.
Anal Biochem 2009;394(1):7–12
51. Carbone R, Marangi I, Zanardi A, Giorgetti L, Chierici E, Berlanda
G, Podest�a A, Fiorentini F, Bongiorno G, Piseri P, Pelicci PG, Milani
P. Biocompatibility of cluster-assembled nanostructured TiO2 with
primary and cancer cells. Biomaterials 2006;27(17) 3221–3329
52. Barborini E, Conti AM, Kholmanov I, Piseri P, Podest�a A, Milani
P, Cepek C, Sakho O, Macovez R, Sancrotti M. Nanostructured
TiO2 Films with 2 eV optical gap. Adv Mater 2005;17(15):
1842–1846
53. Vyas V, Podest�a A, Milani P. Probing nanoscale interactions on
biocompatible cluster-assembled titanium oxide surfaces by
atomic force microscopy. J Nanosci Nanotechnol 2011;11(6):
4739–4748
54. Caruso T, Lenardi C, Mazza T, Policicchio A, Bongiorno G, Agos-
tino RG, Chiarello G, Colavita E, Finetti P, Prince KC, Ducati C,
Piseri P, Milani P. Photoemission investigations on nanostruc-
tured TiO2 grown by cluster assembling. Surf Sci 2007;601(13):
2688–2691
55. Vandamme N, Verschoren G, Depuydt A, Cannaerts M, Bouwen
W, Lievens P, Silverans CE, Van Haesendonck C. Deposition of
gold clusters on atomically flat gold films. Appl Phys A: Mater
Sci Proc 2001;72(8):S177–S180.
56. Barabasi A, Stanley H. Fractal Concepts in Surface Growth—Cam-
bridge Books Online. New York: Cambridge University Press;
1995.
57. Olson CL, Nelson J, Islam MS. Defect chemistry, surface struc-
tures, and lithium insertion in anatase TiO2. J Phys Chem B
2006;110(20):9995–10001
58. Giorgetti L, Bongiorno G, Podest�a A, Berlanda G, Scopelliti PE,
Carbone R, Milani P. Adsorption and stability of streptavidin on
cluster-assembled nanostructured TiOx films. Langmuir 2008;
24(20):11637–11644
59. Fabre RM, Talham DR. Stable supported lipid bilayers on zirco-
nium phosphonate surfaces. Langmuir 2009;25(21):12644–12652
60. Denry I, Kelly JR. State of the art of zirconia for dental applica-
tions. Dent Mater 2008;24(3):299–307
61. Ratner B. The biocompatibility manifesto: biocompatibility for
the twenty-first century. J CardiovasTransl Res 2011:1–5.
62. Oliver RG. In: Brantley WA,Eliades T, editors. Orthodontic Mate-
rials. Scientific and Clinical Aspects.Stuttgart, Germany:Thieme;
2001. p 310.
63. Singh AV, Lenardi C, Gailite L, Gianfelice A, Milani P. A simple
lift-off-based patterning method for micro- and nanostructuring
of functional substrates for cell culture. J Micromech Microeng
2009;19(11):115028
64. Singh AV, Gailite L, Vyas V, Lenardi C, Forti S, Matteoli M,
Milani P. Rapid prototyping of nano- and micro-patterned sub-
strates for the control of cell neuritogenesis by topographic and
chemical cues. Mater Sci Eng C 2011;31(5):892–899
65. Schmidt SR, Waldeck H, Kao WJ. Protein Adsorption to Biomate-
rials. New York, NY: Springer; 2009. p 1–18.
3006 SINGH BOTTOM-UP ENGINEERING TO OPTIMIZE CELL–PROTEIN–SURFACE INTERACTIONS
66. Koegler P, Clayton A, Thissen H, Santos GN, Kingshott P. The
influence of nanostructured materials on biointerfacial interac-
tions. Adv Drug Deliv Rev 2012;64(15):1820–1839
67. Scopelliti PE, Borgonovo A, Indrieri M, Giorgetti L, Bongiorno G,
Carbone R, Podest�a A, Milani P. The effect of surface nano-
metre-scale morphology on protein adsorption. PLoS One 2010;
5(7):e11862.
68. Belicchi M, Erratico S, Razini P, Meregalli M, Cattaneo A, Jac-
chetti E, Farini A, Villa C, Bresolin N, Porretti L, Lenardi C, Milani
P, Torrente Y. Ex vivo expansion of human circulating myogenic
progenitors on cluster-assembled nanostructured TiO2. Biomate-
rials 2010;31(20):5385–5396
69. Scopelliti PE, Giorgetti L, Bongiorno G, Podest�a A, Berlanda G,
Carbone R, Milani P. Adsorption and stability of streptavidin on
cluster-assembled nanostructured TiOx films. Biophys J 2009;
96(3, Suppl 1):50a-a.
70. Giorgetti L, Zanardi A, Venturini S, Carbone R. Immunocell-
array: A novel technology for pathway discovery and cell profil-
ing. Expert Rev Proteomics 2007;4(5):609–616
71. Wheeler DB, Carpenter AE, Sabatini DM. Cell microarrays and
RNA interference chip away at gene function. Nat Genet 2005;
37(6 Suppl):S25–S30.
72. Bailey SN, Ali SM, Carpenter AE, Higgins CO, Sabatini DM.
Microarrays of lentiviruses for gene function screens in immor-
talized and primary cells. Nat Methods 2006;3(2):117–122
73. Wu RZ, Bailey SN, Sabatini DM. Cell-biological applications of
transfected-cell microarrays. Trends Cell Biol 2002;12(10):
485–488
74. Wheeler DB, Bailey SN, Guertin DA, Carpenter AE, Higgins CO, Saba-
tini DM. RNAi living-cell microarrays for loss-of-function screens in
Drosophila melanogaster cells. Nat Methods 2004;1(2):127–132
75. Ziauddin J, Sabatini DM. Microarrays of cells expressing defined
cDNAs. Nature 2001;411(6833):107–110
76. Hubbell JA. Materials as morphogenetic guides in tissue engi-
neering. Curr Opin Biotechnol 2003;14(5):551–558
77. Stevens MM, George JH. Exploring and engineering the cell sur-
face interface. Science 2005;310(5751):1135–1138
78. Haouzi D, Baghdiguian S, Granier G, Travo P, Mangeat P, Hibner
U. Three-dimensional polarization sensitizes hapatocytes to Fas/
CD95 apoptotic signalling. J Cell Sci 2005;118(12):2763–2773
79. Hook AL, Thissen H, Voelcker NH. Surface manipulation of bio-
molecules for cell microarray applications. Trends Biotechnol
2006;24(10):471–477
80. Falconnet D, Csucs G, Michelle Grandin H, Textor M. Surface en-
gineering approaches to micropattern surfaces for cell-based
assays. Biomaterials 2006;27(16):3044–3063
81. Echeverri CJ, Perrimon N. High-throughput RNAi screening in
cultured cells: A user’s guide. Nat Rev Genet 2006;7(5):373–384
82. Jeffrey AH. Materials as morphogenetic guides in tissue engi-
neering. Curr Opin Biotechnol 2003;14(5):551–558
83. Haouzi D, Baghdiguian S, Granier G, Travo P, Mangeat P, Hibner
U. Three-dimensional polarization sensitizes hepatocytes to Fas/
CD95 apoptotic signalling. J Cell Sci 2005;118(12):2763–2773
84. Carbone R, Giorgetti L, Zanardi A, Marangi I, Chierici E, Bon-
giorno G, Fiorentini F, Faretta M, Piseri P, Pelicci PG, Milani P.
Retroviral microarray-based platform on nanostructured TiO2 for
functional genomics and drug discovery. Biomaterials 2007;
28(13):2244–2253
85. Legrain P, Aebersold R, Archakov A, Bairoch A, Bala K, Beretta
L, Bergeron J, Borchers CH, Corthals GL, Costello CE, Deutsch
EW, Domon B, Hancock W, He F, Hochstrasser D, Marko-Varga
G, Salekdeh GH, Sechi S, Snyder M, Srivastava S, Uhl�en M, Wu
CH, Yamamoto T, Paik YK, Omenn GS. The human proteome
project: current state and future direction. Mol Cell Proteomics
2011;10(7).
86. Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome
for cancer biomarkers. Nature 2008;452(7187):571–579
87. Harrison PM, Kumar A, Lang N, Snyder M, Gerstein M. A ques-
tion of size: The eukaryotic proteome and the problems in defin-
ing it. Nucleic Acids Res 2002;30(5):1083–1090
88. Bertone P, Snyder M. Advances in functional protein microarray
technology. FEBS J 2005;272(21):5400–5411
89. Saerens D, Ghassabeh GH, Muyldermans S. Antibody technol-
ogy in proteomics. Brief Funct Genomics Proteomics 2008;7(4):
275–282
90. Ling MM, Ricks C, Lea P. Multiplexing molecular diagnostics and
immunoassays using emerging microarray technologies. Expert
Rev Mol Diagn 2007;7(1):87–98
91. Saerens D, Ghassabeh GH, Muyldermans S. Antibody technol-
ogy in proteomics. Brief Funct Genomics Proteomics 2008;7(4):
275–282
92. Kasemo B, Gold J. Implant surfaces and interface processes.
Adv Dent Res 1999;13(1):8–20
93. Zanardi A, Giorgetti L, Botrugno OA, Minucci S, Milani P, Pelicci
PG, Carbone R. Immunocell-array for molecular dissection of
multiple signaling pathways in mammalian cells. Mol Cell Pro-
teomics 2007;6(5):939–947
94. Sevecka M, Wolf-Yadlin A, MacBeath G. Lysate microarrays ena-
ble high-throughput, quantitative investigations of cellular sig-
naling. Mol Cell Proteomics 2011;10(4):M110.005363.
95. Liotta LA, Kohn EC, Petricoin EF. Clinical Proteomics. JAMA
2001;286(18):2211–2214
96. Petricoin EF 3rd, Bichsel VE, Calvert VS, Espina V, Winters M,
Young L, Belluco C, Trock BJ, Lippman M, Fishman DA, Sgroi
DC, Munson PJ, Esserman LJ, Liotta LA. Mapping molecular net-
works using proteomics: A vision for patient-tailored combina-
tion therapy. J Clin Oncol 2005;23(15):3614–3621
97. Spurrier B, Ramalingam S, Nishizuka S. Reverse-phase protein
lysate microarrays for cell signaling analysis. Nat Protoc 2008;
3(11):1796–1808
98. Chan SM, Ermann J, Su L, Fathman CG, Utz PJ. Protein microar-
rays for multiplex analysis of signal transduction pathways. Nat
Med 2004;10(12):1390–1396
99. Cadigan KM, Liu YI. Wnt signaling: Complexity at the surface. J
Cell Sci 2006;119(3):395–402
100. Tomilin NV, Solovjeva LV, Svetlova MP, Pleskach NM, Zalen-
skaya IA, Yau PM, Bradbury EM. Visualization of focal nuclear
sites of DNA repair synthesis induced by bleomycin in human
cells. Radiat Res 2001;156(4):347–354
101. Giorgetti L, Zanardi A, Venturini S, Carbone R. Immunocell-
array: A novel technology for pathways discovery and cell profil-
ing 2007;4(5):609–616
102. Ronzoni S, Faretta M, Ballarini M, Pelicci P, Minucci S. New
method to detect histone acetylation levels by flow cytometry.
Cytometry Part A 2005;66A(1):52–61.
103. Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler
SJ. Multidimensional drug profiling by automated microscopy.
Science 2004;306(5699):1194–1198
104. Francavilla C, Cattaneo P, Berezin V, Bock E, Ami D, de Marco A,
Christofori G, Cavallaro U. The binding of NCAM to FGFR1 indu-
ces a specific cellular response mediated by receptor trafficking.
J Cell Biol 2009;187(7):1101–1116
105. Guilleaume B, Buneß A, Schmidt C, Klimek F, Moldenhauer G,
Huber W, Arlt D, Korf U, Wiemann S, Poustka A. Systematic
comparison of surface coatings for protein microarrays. Proteo-
mics 2005;5(18):4705–4712
106. De Marni ML, Monegal A, Venturini S, Vinati S, Carbone R, de Marco
A. Antibody purification-independent microarrays (PIM) by direct
bacteria spotting on TiO2-treated slides. Methods 2012;56:317–325.
107. Bengt K. Biological surface science. Curr Opin Solid State Mater
Sci 1998;3(5):451–459
108. Lipski AM, Jaquiery C, Choi H, Eberli D, Stevens M, Martin I,
Chen IW, Sastry PV. Nanoscale engineering of biomaterial surfa-
ces. Adv Mater 2007;19(4):553–557
109. Rocker C, Potzl M, Zhang F, Parak WJ, Nienhaus GU. A quantita-
tive fluorescence study of protein monolayer formation on col-
loidal nanoparticles. Nat Nano 2009;4(9):577–580
110. Nel AE, M€adler L, Velegol D, Xia T, Hoek EMV, Somasundaran P,
Klaessig F, Castranova V, Thompson M. Understanding biophy-
sicochemical interactions at the nano–bio interface. Nat Mater
2009;8(7):543–557
111. Roach P, Farrar D, Perry CC. Interpretation of protein adsorption:
Surface-induced conformational changes. J Am Chem Soc 2005;
127(22):8168–8173
REVIEW ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | OCT 2013 VOL 101A, ISSUE 10 3007
112. Roach P, Farrar D, Perry CC. Surface tailoring for controlled pro-
tein adsorption: Effect of topography at the nanometer scale and
chemistry. J Am Chem Soc 2006;128(12):3939–3945
113. Chayen NE, Saridakis E, Sear RP. Experiment and theory for het-
erogeneous nucleation of protein crystals in a porous medium.
Proc Natl Acad Sci USA 2006;103(3):597–601
114. Zanardi A, Bandiera B, Bertolini F, Corsini CA, Gregato G, Milani P,
Barborini E, Carbone R. Miniaturized FISH for screening of onco-
hematological malignancies. Biotechniques 2010;49:497–504.
115. Lenardi C, Perego C, Cassina V, Podest�a A, D’Amico A, Gualand-
ris D, Vinati S, Fiorentini F, Bongiorno G, Piserj P, Vellea Sacchi
F, Milani P. Adhesion and proliferation of fibroblasts on cluster-
assembled nanostructured carbon films: The role of surface mor-
phology. J Nanosci Nanotechnol 2006;6(12):3718–3730
116. Singh AV, Galuzzi M, Borghi F, Vyas V, Podesta A, Indrieri M,
Gade WN. Interaction of bacterial cells with cluster-assembled
nanostructured titania surfaces: An atomic force microscopy
study. J Nanosci Nanotechnol 2013;13:77–85.
3008 SINGH BOTTOM-UP ENGINEERING TO OPTIMIZE CELL–PROTEIN–SURFACE INTERACTIONS
Top Related